Brief: Moberg Pharma July-Sept EBITDA Turns To Profit Of SEK 24.4 Mln
Nov 10 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* JULY-SEPT NET REVENUE SEK 50.5 MILLION (15.6) *
* JULY-SEPT EBITDA SEK 24.4 MILLION (-3.0) *
Source text for Eikon: ID:nWkr3X83Mz
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))